Trials / Recruiting
RecruitingNCT05495048
Transvaginal NOSES Versus Conventional Laparoscopic Surgery for Right Hemicolectomy
Transvaginal Natural Orifice Specimen Extraction Surgery Versus Conventional Laparoscopic Surgery With Mini-laparotomy in Right Hemicolectomy for Colon Cancer: a Randomised, Controlled, Phase 3, Non-inferiority Trial (NOSES VIIIA Trial)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 356 (estimated)
- Sponsor
- Shanghai Minimally Invasive Surgery Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
It is controversial that totally laparoscopic right hemicolectomy with transvaginal natural orifice specimen extraction (NOSES VIIIA) can provide non-inferior oncological outcomes compared to conventional laparoscopic surgery with mini-laparotomy in the treatment of right colon cancer. We aim to carry out a multicenter, open-lable, parallel, non-inferiority, phase III, randomized controlled clinical trial, which enrolls 356 female patients with cT1-3NxM0 right colon adenocarcinoma. They are randomly assigned to the experimental group (NOSES VIIIA) or the control group (laparoscopic surgery with mini-laparotomy) in a 1:1 ratio. Perioperative indicators, pathological results, quality of life and cosmetic evaluation will be compared between the two groups. Then, a three-year follow-up of these patients will provide evidence for long-term oncological outcomes of NOSES VIIIA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | NOSES VIIIA | totally laparoscopic right hemicolectomy with transvaginal natural orifice specimen extraction |
| PROCEDURE | laparoscopic surgery with mini-laparotomy | laparoscopic right hemicolectomy with trans-abdominal extraction from a mini-laparotomy |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2022-08-10
- Last updated
- 2024-02-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05495048. Inclusion in this directory is not an endorsement.